Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Power List / 2016 / Honorees / Jerry Shields

Jerry Shields

  • Profile

About Jerry Shields

Jerry Shields

Professor, Thomas Jefferson University; Co-Director, Wills Eye Hospital Ocular Oncology Service, Philadelphia, Pennsylvania

Shields established the Wills Eye Ocular Oncology service in 1974. He has published more than 800 articles, with his main interest being choroidal melanoma and retinoblastoma. He has pioneered the use of many new ocular anticancer therapies, and was instrumental in popularizing plaque radiotherapy for the treatment of choroidal melanoma. With his colleagues, he has improved the techniques of local irradiation, local surgical resection, laser photocoagulation, and thermotherapy. His research resulted in improvements in the diagnosis and treatment of many benign and malignant tumor types, such as tumors of the ciliary body epithelium, pigment epithelium, and leiomyomas. He has authored or co-authored more than 1,200 articles and textbook chapters, and has authored or co-authored 13 major textbooks related to ocular tumors. He continues to be a leader in eye cancer research, both nationally and internationally.


Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: